Locus coeruleus neurons from morphine-treated rats do not show opiate- withdrawal hyperactivity in vitro

Brain Research

Volumn 788, Issue 1-2, 1998, Pages 237-244

  Bell, James A ^a   Grant, Steven J ^a  

^a Brain Imaging Section   (United States)

Author keywords

Brain slice; Locus coeruleus; Morphine; Naloxone; Opiate dependence

Indexed keywords

MORPHINE; NALOXONE; OPIATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; IN VITRO STUDY; LOCUS CERULEUS; NERVE CELL EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0032579889     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00003-1     Document Type: Article

References (28)

1. Aghajanian G.K. Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature. 276:1978;186-188.
2. Aghajanian G.K., Kogan J.H., Moghaddam B. Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study. Brain Res. 636:1994;126-130.
3. Aghajanian G.K., Rasmussen K. Intracellular studies in the facial nucleus illustrating a simple new method for obtaining viable motoneurons in adult rat brain slices. Synapse. 3:1989;331-338.
4. Akaoka H., Aston-Jones G. Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input. J. Neurosci. 11:1991;3830-3839.
5. Alreja M., Aghajanian G.K. Pacemaker activity of locus coeruleus neurons: whole-cell recordings in brain slices show dependence on cAMP and protein kinase A. Brain Res. 556:1991;339-343.
6. Andrade R., Vandermaelen C.P., Aghajanian G.K. Morphine tolerance and dependence in the locus coeruleus: single cell studies in the brain slices. Eur. J. Pharmacol. 91:1983;161-169.
7. Bonci A., Williams J.T. Increased probability of GABA release during withdrawal from morphine. J. Neurosci. 17:1997;796-803.
8. Chieng B., Christie M.J. Local opioid withdrawal in rat single periaqueductal gray neurons in vitro. J. Neurosci. 16:1996;7128-7136.
9. Christie M.J., Williams J.T., North R.A. Cellular mechanisms of opioid tolerance: studies in single brain neurons. Mol. Pharmacol. 32:1987;633-638.
10. M.S. Gold, D.E. Redmond, Jr., H.D. Kleber, Clonidine blocks acute opiate-withdrawal symptoms, Lancet, 1978, pp. 599-602.
11. Hyman S.E. Shaking out the cause of addiction. Science. 273:1996;611-612.
12. Kennedy C., Henderson G. Chronic exposure to morphine does not induce dependence at the level of the calcium channel current in human SH-SY5Y cells. Neuroscience. 49:1992;937-944.
13. Kimes A.S., Bell J.A., London E.D. Clonidine attenuates increased brain glucose metabolism during naloxone-precipitated morphine withdrawal. Neuroscience. 34:1990;633-644.
14. Kogan J.H., Nestler E.J., Aghajanian G.K. Elevated basal firing rates and enhanced responses to 8-Br-cAMP in locus coeruleus neurons in brain slices from opiate-dependent rats. Eur. J. Pharmacol. 211:1992;47-53.
15. Korf J., Bunney B.S., Aghajanian G.K. Noradrenergic neurons: morphine inhibition of spontaneous activity. Eur. J. Pharmacol. 25:1974;165-169.
16. Maldonado R., Blendy J.A., Tzavara E., Gass P., Roques B.P., Hanoune J., Schutz G. Reduction of morphine abstinence in mice with a mutation in the gene encoding CREB. Science. 273:1996;657-659.
17. Maldonado R., Koob G.F. Destruction of the locus coeruleus decreases physical signs of opiate withdrawal. Brain Res. 605:1993;128-138.
18. Maldonado R., Stinus L., Gold L.H., Koob G.F. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther. 261:1992;669-677.
19. Nestler E.J. Under siege: the brain on opiates. Neuron. 16:1996;897-900.
20. Nestler E.J., Tallman J.F. Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus. Mol. Pharmacol. 33:1988;127-132.
21. Rasmussen K., Aghajanian G.K. Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: attenuation by lesions of the nucleus paragigantocellularis. Brain Res. 505:1989;346-350.
22. Rasmussen K., Beitner-Johnson D., Krystal J.H., Aghajanian G.K., Nestler E.J. Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. J. Neurosci. 10:1990;2308-2317.
23. Rasmussen K., Fuller R.W., Stockton M.E., Perry K.W., Swinford R.M., Ornstein P.L. NMDA receptor antagonists suppress behaviors but not norepinephine turnover or locus coeruleus unit activity induced by opiate withdrawal. Eur. J. Pharmacol. 197:1989;9-16.
24. Rasmussen K., Krystal J.H., Aghajanian G.K. Excitatory amino acids and morphine withdrawal: differential effects of central and peripheral kynurenic acid administration. Psychopharmacology (Berlin). 105:1991;508-512.
25. Redmond D.E. Jr., Krystal J.H. Multiple mechanisms of withdrawal from opioid drugs. Annu. Rev. Neurosci. 7:1984;443-478.
26. Schultz R., Wuster M., Krenss H., Herz A. Selective development of tolerance without dependence in multiple opiate receptors of mouse vas deferens. Nature. 285:1980;242-243.
27. Valentino R.J., Wehby R.G. Locus ceruleus discharge characteristics of morphine-dependent rats: effects of naltrexone. Brain Res. 488:1989;126-134.
28. Wikler, A., Conditioning factors in opiate addiction and relapse. In: D.M. Wilner, G.G. Kassebaum (Eds.), Narcotics, McGraw-Hill, New York, 1965, pp. 83-100.